A Study in Adults With Type 2 Diabetes

• Status: Completed
• Trial end date: 2012-09-01

Summary

The main purpose of this study is to compare the effectiveness and safety of LY2963016 versus Lantus in controlling blood sugar levels in combination with two or more oral diabetes medications.

• Phase: Phase 3

Details

• Lead Sponsor: Eli Lilly and Company
• Collaborator: Boehringer Ingelheim
• Treatments: Insulin Glargine